These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2748)

  • 21. Studies on absorption and elimination of drugs.
    Ksiezyk M; Danek A
    Int J Clin Pharmacol; 1973 Nov; 8(3):222-7. PubMed ID: 4272488
    [No Abstract]   [Full Text] [Related]  

  • 22. [Model building in pharmacokinetics/Part II: Generalized theoretical presentation of complete integration of linear compartment models of optional structure (author's transl)].
    Wolf M; Heinzel G; Koss FW; Bozler G
    Arzneimittelforschung; 1977; 27(4a):900-4. PubMed ID: 577857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model.
    Byron PR; Notari RE
    J Pharm Sci; 1976 Aug; 65(8):1140-4. PubMed ID: 978432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 25. [The prediction of enantiomeric differences in the pharmacokinetic parameters of drugs by using a physiological perfusion model].
    Piotrovskiĭ VK; Shvachko EV; Trnovec T
    Eksp Klin Farmakol; 1994; 57(5):37-40. PubMed ID: 7696904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Kidney and drugs - urinary lithiasis. Pharmacokinetic glossary].
    Balant L
    Rev Med Suisse Romande; 1980 Nov; 100(11):949-56. PubMed ID: 7466067
    [No Abstract]   [Full Text] [Related]  

  • 27. NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models.
    Weiner DL
    Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):625-8. PubMed ID: 3784700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.
    Wagner JG; Szpunar GJ; Ferry JJ
    Drug Metab Dispos; 1984; 12(4):385-8. PubMed ID: 6148202
    [No Abstract]   [Full Text] [Related]  

  • 29. [Estimation of pharmacokinetic constants in irregular repeated drug administration (author's transl)].
    Ringwelski L; Krause D
    Arzneimittelforschung; 1978; 28(10):1766-70. PubMed ID: 582681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Compartment analysis, a method for the study of the kinetics of metabolism].
    Skalicky M; Leibetseder J; Kment A
    Zentralbl Veterinarmed A; 1976 Sep; 23(7):588-99. PubMed ID: 824914
    [No Abstract]   [Full Text] [Related]  

  • 31. Bioavailability studies of calcium dobesilate--a case of flip-flop kinetics.
    Franke G; Schneider T; Siegmund W; Scherber A
    Pharmazie; 1985 Aug; 40(8):562-3. PubMed ID: 4080804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontiers in pharmacokinetic data analysis.
    Drug Metab Rev; 1984; 15(1-2):1-400. PubMed ID: 6745078
    [No Abstract]   [Full Text] [Related]  

  • 33. The problem of choosing weights in nonlinear regression analysis of pharmacokinetic data.
    Peck CC; Sheiner LB; Nichols AI
    Drug Metab Rev; 1984; 15(1-2):133-48. PubMed ID: 6745079
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of drug absorption after oral administration.
    Chan KK; Gibaldi M
    J Pharm Sci; 1985 Apr; 74(4):388-93. PubMed ID: 3998998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-compartment pharmacokinetic models: computer simulations of their characteristics and clinical consequences.
    Abramson FP
    J Pharm Sci; 1981 Feb; 70(2):141-6. PubMed ID: 7205215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of parameters in pharmacokinetic analysis [proceedings].
    House FR
    Br J Clin Pharmacol; 1979 Apr; 7(4):432P-433P. PubMed ID: 444382
    [No Abstract]   [Full Text] [Related]  

  • 37. Computation of model-independent pharmacokinetic parameters during multiple dosing.
    Bauer LA; Gibaldi M
    J Pharm Sci; 1983 Aug; 72(8):978-9. PubMed ID: 6620166
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of change in elimination on varous parameters of the two-compartment open model.
    Jusko WJ; Gibaldi M
    J Pharm Sci; 1972 Aug; 61(8):1270-3. PubMed ID: 5050376
    [No Abstract]   [Full Text] [Related]  

  • 39. Composite pharmacokinetic profiling.
    Colburn WA; Gibson DM
    J Pharm Sci; 1984 Nov; 73(11):1667-9. PubMed ID: 6097666
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetic criteria for the evaluation of retard formulations.
    Meier J; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1974 Oct; 7(6):429-32. PubMed ID: 4155170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.